Supha Pharmachem (BOM:539561) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 30, 2026)


BOM:539561 Supha Pharmachem Ltd BOM:539561
58 GF Score
Price ₹0.30
GF Value ₹1.53
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Supha Pharmachem's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:539561 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Supha Pharmachem's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Supha Pharmachem Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Supha Pharmachem's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Supha Pharmachem's Margin of Safety % (DCF Earnings Based) falls into.


BOM:539561
58GF Score
Supha Pharmachem Ltd BOM:539561
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.30 is trading 80.4% below its estimated GF Value™ of ₹1.53. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹1.53 vs. price of ₹0.30 (80.4% below fair value)
  • GF Score™: 58/100 with 12 warning signs

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
58GF Score

Get the complete analysis for BOM:539561

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.30
Price
₹1.53
GF Value